Heron Therapeutics HRTX reported its Q4 earnings results on Tuesday, March 12, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Heron Therapeutics beat estimated earnings by 56.00000000000001%, reporting an EPS of $-0.07 versus an estimate of $-0.16.
Revenue was up $4.21 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.12 which was followed by a 59.0% increase in the share price the next day.
Here's a look at Heron Therapeutics's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.29 | -0.23 | -0.20 | -0.28 |
| EPS Actual | -0.17 | -0.35 | -0.27 | -0.17 |
| Revenue Estimate | 32.75M | 31.70M | 29.69M | 26.90M |
| Revenue Actual | 31.43M | 31.76M | 29.61M | 30.03M |
To track all earnings releases for Heron Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
